These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
710 related items for PubMed ID: 33982858
1. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study. Lupattelli A, Mahic M, Handal M, Ystrom E, Reichborn-Kjennerud T, Nordeng H. BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858 [Abstract] [Full Text] [Related]
2. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study. Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, Lau WCY, Schuemie MJ, Sturkenboom MCJM, Wong ICK. BMJ; 2017 May 31; 357():j2350. PubMed ID: 28566274 [Abstract] [Full Text] [Related]
3. Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children. Boukhris T, Sheehy O, Bérard A. Paediatr Perinat Epidemiol; 2017 Jul 31; 31(4):363-373. PubMed ID: 28640459 [Abstract] [Full Text] [Related]
4. Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children. Trønnes JN, Lupattelli A, Handal M, Skurtveit S, Ystrom E, Nordeng H. JAMA Netw Open; 2021 Sep 01; 4(9):e2124324. PubMed ID: 34524436 [Abstract] [Full Text] [Related]
5. Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers. Lupattelli A, Chambers CD, Bandoli G, Handal M, Skurtveit S, Nordeng H. JAMA Netw Open; 2019 Apr 05; 2(4):e191435. PubMed ID: 30951155 [Abstract] [Full Text] [Related]
6. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data. Singal D, Brownell M, Chateau D, Ruth C, Katz LY. BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401 [Abstract] [Full Text] [Related]
7. Antidepressant use during pregnancy and the risk of attention-deficit/hyperactivity disorder in the children: a meta-analysis of cohort studies. Jiang HY, Peng CT, Zhang X, Ruan B. BJOG; 2018 Aug 29; 125(9):1077-1084. PubMed ID: 29243299 [Abstract] [Full Text] [Related]
8. Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study. Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, Weissman M, Wickramaratne P, Artama M, Gingrich JA, Sourander A. J Am Acad Child Adolesc Psychiatry; 2016 May 29; 55(5):359-66. PubMed ID: 27126849 [Abstract] [Full Text] [Related]
9. Prenatal exposure to non-steroidal anti-inflammatory drugs and risk of attention-deficit/hyperactivity disorder: A follow-up study in the Norwegian mother, father and child cohort. Hjorth S, Lupattelli A, Handal M, Spigset O, Ystrom E, Nordeng H. Pharmacoepidemiol Drug Saf; 2021 Oct 29; 30(10):1380-1390. PubMed ID: 33866622 [Abstract] [Full Text] [Related]
10. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study. Lupattelli A, Wood M, Lapane K, Spigset O, Nordeng H. Pharmacoepidemiol Drug Saf; 2017 Oct 29; 26(10):1266-1276. PubMed ID: 28815791 [Abstract] [Full Text] [Related]
11. Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood. Sundbakk LM, Gran JM, Wood ME, Handal M, Skurtveit S, Nordeng H. JAMA Netw Open; 2022 Dec 01; 5(12):e2246889. PubMed ID: 36520439 [Abstract] [Full Text] [Related]
12. Prenatal Paternal Selective Serotonin Reuptake Inhibitors Use and Risk of ADHD in Offspring. Yang F, Liang H, Chen J, Miao M, Yuan W, Nørgaard M, Li J. Pediatrics; 2018 Jan 01; 141(1):. PubMed ID: 29229680 [Abstract] [Full Text] [Related]
13. Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway. Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M. BJOG; 2014 Dec 01; 121(13):1621-31. PubMed ID: 24726047 [Abstract] [Full Text] [Related]
14. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory. Koc D, Tiemeier H, Stricker BH, Muetzel RL, Hillegers M, El Marroun H. JAMA Psychiatry; 2023 Dec 01; 80(12):1208-1217. PubMed ID: 37647036 [Abstract] [Full Text] [Related]
15. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. Figueroa R. J Dev Behav Pediatr; 2010 Oct 01; 31(8):641-8. PubMed ID: 20613624 [Abstract] [Full Text] [Related]
16. In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners. Singal D, Chateau D, Struck S, Lee JB, Dahl M, Derksen S, Katz LY, Ruth C, Hanlon-Dearman A, Brownell M. Pediatrics; 2020 May 01; 145(5):. PubMed ID: 32341177 [Abstract] [Full Text] [Related]
17. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure. Rotem-Kohavi N, Oberlander TF. Birth Defects Res; 2017 Jul 17; 109(12):909-923. PubMed ID: 28714603 [Abstract] [Full Text] [Related]
18. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A. JAMA Psychiatry; 2016 Nov 01; 73(11):1163-1170. PubMed ID: 27732704 [Abstract] [Full Text] [Related]
19. Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study. Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R. BJOG; 2016 Nov 01; 123(12):1908-1917. PubMed ID: 26374234 [Abstract] [Full Text] [Related]
20. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia. Colvin L, Slack-Smith L, Stanley FJ, Bower C. CNS Drugs; 2012 Jul 01; 26(7):e1-14. PubMed ID: 22712699 [Abstract] [Full Text] [Related] Page: [Next] [New Search]